Medical Disclaimer

Last Updated: April 14, 2026

⚠️ IMPORTANT: This calculator provides estimates based on clinical trial averages. Individual results vary significantly. This tool is NOT a substitute for professional medical advice. Always consult your healthcare provider before starting any weight loss medication.

1. Nature of the Calculator

The Free Semaglutide Calculator is an educational tool designed to provide approximate weight loss projections based on statistical averages derived from peer-reviewed clinical trials. The calculator uses data from the following landmark studies:

Clinical Trial Data Sources

  • STEP-1 Trial (Semaglutide 2.4mg - Wegovy): A 68-week randomized, double-blind, placebo-controlled trial of 1,961 adults with obesity. Average weight loss: ~16.9% of body weight.
  • SUSTAIN Trials (Semaglutide 1mg - Ozempic): Clinical trials demonstrating 10.5% average weight loss over 68 weeks at 1mg weekly dose for type 2 diabetes management.
  • SURMOUNT-1 Trial (Tirzepatide 15mg - Mounjaro/Zepbound): A 72-week trial showing average weight loss of ~22.5% at the 15mg maintenance dose.
  • SCALE Trial (Liraglutide 3mg - Saxenda): A 56-week trial with average weight loss of ~8% at the 3mg daily dose.

2. Individual Variability

The projections provided by this calculator are based on population-level averages. Your actual results may differ substantially due to numerous individual factors, including but not limited to:

3. Not a Substitute for Medical Advice

This calculator does NOT replace the professional judgment of a licensed healthcare provider. You should:

4. FDA Disclaimer

The statements and projections made by this calculator have not been evaluated by the U.S. Food and Drug Administration (FDA). This tool is not intended to diagnose, treat, cure, or prevent any disease.

FDA-Approved Indications:

5. Potential Risks and Side Effects

GLP-1 receptor agonists carry risks and potential side effects, including:

6. Pregnancy and Breastfeeding

GLP-1 medications are not recommended during pregnancy or breastfeeding. If you are pregnant, planning to become pregnant, or breastfeeding, consult your healthcare provider before using any GLP-1 medication. Semaglutide and tirzepatide should be discontinued at least 2 months before a planned pregnancy.

7. No Guarantee of Weight Loss

We make no guarantees, warranties, or representations that you will achieve any specific weight loss outcome. The calculator provides estimates based on average clinical trial results, and your individual experience may differ. Some users may experience minimal weight loss or even weight gain.

8. Long-Term Maintenance Considerations

Clinical evidence suggests that discontinuing GLP-1 medications often results in weight regain. Long-term use may be required to maintain weight loss. Discuss a sustainable maintenance plan with your healthcare provider.

9. Accuracy of Calculator Inputs

The accuracy of the calculator's projections depends on the accuracy of the information you provide (current weight, goal weight, height, age, sex, activity level, medication). Inaccurate inputs will produce inaccurate projections.

10. No Doctor-Patient Relationship

Use of this calculator does not create a doctor-patient relationship between you and the operators of this website. This tool is for informational purposes only and should not replace individualized medical counseling.

11. Limitation of Liability

To the fullest extent permitted by law, the operators of Free Semaglutide Calculator shall not be liable for any health complications, adverse events, injuries, or damages resulting from:

12. Emergency Medical Situations

If you experience a medical emergency or severe side effects while using GLP-1 medications, call 911 or seek immediate medical attention. Do not rely on this website for emergency medical guidance.

13. Contact Information

If you have questions about this Medical Disclaimer, please contact us at:

Email: contact@freesemaglutidecalculator.com